✦ LIBER ✦

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled trial

✍ Scribed by Roeland Huijgen; Evertine J. Abbink; Eric Bruckert; Anton F.H. Stalenhoef; Ben P.M. Imholz; Paul N. Durrington; M.D. Trip; Mats Eriksson; Frank L.J. Visseren; Juergen R. Schaefer; John J.P. Kastelein

Book ID: 113544211
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 150 KB
Volume: 32
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2010.04.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of esreboxetine in p

Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial

✍ Lesley M. Arnold; Ian Hirsch; Paul Sanders; Amanda Ellis; Bernadette Hughes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Cardiac Safety Profile of Nebulized Form

Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial

✍ Harold S. Nelson; Nicholas J. Gross; Bernard Levine; Edward M. Kerwin; Mike Rine 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Losartan versus valsartan in the treatme

Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial

✍ William J. Elliott; David A. Calhoun; Paul T. DeLucca; Lisa P. Gazdick; Dawn E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Dutogliptin, a selective DPP4 inhibitor,

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial

✍ H. M. R. Pattzi; S. Pitale; M. Alpizar; C. Bennett; A. M. O’Farrell; J. Li; J. M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Infliximab monotherapy in Japanese patie

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

✍ Torii, Hideshi; Nakagawa, Hidemi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Treatment of rheumatoid arthritis with a

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four–week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Stanley Cohen; Eric Hurd; John Cush; Michael Schiff; Michael E. Weinblatt; Larry 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views